Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 21, 2011
MEDIFAST, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
000-23016
|
|
13-3714405
|
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer Ident. No.)
|
|
11445 Cronhill Drive, Owing Mills, Maryland
|
|
21117
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area code (410)-581-8042
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure
The following information is furnished under “Item 7.01. Regulation FD Disclosure”
On April 21, 2011, Medifast, Inc. (“Medifast”) issued a press release containing the fiscal 2010 statement to shareholders. A copy of Medifast, Inc.’s press release is attached hereto as Exhibit 99.1 and hereby incorporated by reference.
Item 9.01 Exhibits
Exhibits pursuant to Item 7.01
99.1 Press release dated April 21, 2011, Medifast, Inc. 2010 Statement to Shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
MEDIFAST, INC. |
|
| |
|
|
|
|
|
|
/s/ Michael S. McDevitt |
|
| |
|
Michael S. McDevitt
|
|
| |
|
Chief Executive Officer |
|